ELVNYSEHospital & Medical Service PlansUS GAAP · USD

Elevance Health, Inc.

Elevance Health is a U.S. health benefits and services company built around Blue Cross Blue Shield-branded medical plans and a growing Carelon services platform. It sells medical, pharmacy, behavioral health, and care-management solutions that are designed to coordinate care across the full health journey for members, employers, and public programs.

Revenue199.1bn USD
+12.5 %y/y
Operating profit (EBIT)7,199m USD
−8.4 %y/y
EBIT margin3.6%
−0.8 ppy/y
Net income5,662m USD
−5.3 %y/y
Free cash flow3,174m USD
−30.3 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

050100150200bn USD2020: 121.9 bn USD2020: EBIT 6.4 bn USD20202021: 138.6 bn USD2021: EBIT 7.5 bn USD20212022: 156.6 bn USD2022: EBIT 8.5 bn USD20222023: 171.3 bn USD2023: EBIT 8.5 bn USD20232024: 177.0 bn USD2024: EBIT 7.9 bn USD20242025: 199.1 bn USD2025: EBIT 7.2 bn USD2025199.17.2
RevenueOperating profit (EBIT)

Business

Share of revenue
Health Benefits78 %

Commercial, Medicare, Medicaid, Individual ACA and other medical insurance products sold under BCBS, Anthem, Wellpoint and related brands.

CarelonRx14 %

Pharmacy benefit and pharmacy services platform serving affiliated and unaffiliated customers, including product revenue and service fees.

Carelon Services8 %

Care management, behavioral health, specialty care, post-acute and other health services delivered through the Carelon portfolio.

Customers

Elevance sells to a mix of individual members, employer groups, and government-sponsored programs, with membership spanning commercial, Medicare, Medicaid, BlueCard and FEP populations. It also serves pharmacy customers and other health-related clients through CarelonRx and Carelon services, where buyers want lower-cost access, administrative support, and integrated care management.

Employer Group

Employers buy medical and pharmacy benefits for employees and dependents, with pricing, network breadth and service quality driving retention.

Medicare

Seniors buy Medicare Advantage and related plans that combine medical coverage with care management and network access.

Medicaid

State and managed Medicaid programs buy coverage and administration for low-income and higher-acuity populations.

Individual / ACA

Individuals buy exchange and off-exchange plans where premium pricing and benefit design are key purchase drivers.

Pharmacy and Health Services Clients

Unaffiliated pharmacy and care clients buy CarelonRx and Carelon services for PBM, care management and specialty solutions.

Strategy

Elevance is focused on integrated, whole-health offerings that combine medical, pharmacy and behavioral services across the care journey. Near term, it is expanding Carelon capabilities, growing Medicare Advantage and Individual ACA membership, and using pricing, network quality and data-driven bid discipline to defend share in competitive and regulated markets.

Expand Carelon servicesMedium term

Diversifies earnings beyond core insurance and increases cross-sell across the care journey.

Grow Medicare and Individual ACA membershipShort term

These lines can add scale and support premium growth when pricing reflects medical trends.

Improve whole-health integrationMedium term

Combining medical, pharmacy and behavioral services can improve outcomes and customer retention.

Geography

Elevance is primarily a U.S. business and is licensed to conduct insurance operations in all 50 states, the District of Columbia and Puerto Rico. Its strongest positions are in Blue Cross Blue Shield service areas such as California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia and Wisconsin, where local network depth and brand recognition matter most.

Risks

The main risk is medical cost inflation and pricing error: if premiums and government bids do not keep pace with utilization, margins compress quickly. The company also faces heavy regulatory, competitive and execution risk because it depends on state/federal program pricing, provider network economics, and large technology systems that must remain secure and integrated.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Medical cost inflation and pricing mismatch1Government rate and bid dependence2Cybersecurity and information systems failure3Competitive pressure in managed care4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Medical cost inflation and pricing mismatchImpact: HighLikelihood: High

    If claims trends rise faster than premiums or bids, underwriting profitability declines.

    ExposureHealth BenefitsMedicareMedicaid
  2. Government rate and bid dependenceImpact: HighLikelihood: High

    Medicare and Medicaid results depend on timely approvals and adequate reimbursement.

    ExposureState Medicaid programsMedicare Advantage
  3. Cybersecurity and information systems failureImpact: HighLikelihood: Medium

    Claims, member service and pharmacy operations rely on large, interconnected systems.

    Exposure: Enterprise-wide operations

  4. Competitive pressure in managed careImpact: MediumLikelihood: Medium

    Rivals compete on price, network breadth, service and digital capabilities.

    ExposureCommercialGovernmentNational accounts

Accounting

Judgemental items
Medical claims payable

Reserve estimates depend on utilization, trend assumptions and lagged claims data.

Impact: Can materially change benefit expense and operating margin

Premium rate deferrals

Delayed government approvals can postpone recognition of premium increases.

Impact: Can shift revenue and earnings between quarters

Goodwill and intangible assets

Acquisitions such as CareBridge create impairment risk if expected synergies do not materialize.

Impact: Could lead to non-cash write-downs

Investments and fair value

Investment valuations and market movements affect reported assets and income.

Impact: Can influence non-operating results

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026